Inspire Medical Systems Stock (NYSE:INSP)
Previous Close
$72.66
52W Range
$38.91 - $147.03
50D Avg
$67.43
200D Avg
$59.19
Market Cap
$2.06B
Avg Vol (3M)
$796.90K
Beta
0.73
Div Yield
-
INSP Company Profile
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA. Additionally, the company is pioneering a novel, closed-loop technology designed to continuously track a patient's breathing patterns and administer mild stimulation to the hypoglossal nerve, thereby maintaining an open airway. Founded in 2007, Inspire Medical Systems maintains its corporate headquarters in Golden Valley, Minnesota.